Antihyperglycemic effect of aqueous extract from colubrina elliptica;Efecto antihiperglucémico de un extracto acuoso de colubrina elliptica

Revista Mexicana de Ciencias Farmaceuticas

Volumn 36, Issue 3, 2005, Pages 27-32

  Marroquín Segura, Rubén ^a   Flores P, Maurilio ^a   García B, Martha Mercedes ^b   Mora G, José Luis Alfredo ^a   Sánchez R, Juan Francisco ^a   Aguilar C, Abigail ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Antidiabetic activity; Antihyperglycemic effect; Colubrina elliptica; Diabetes mellitus control

Indexed keywords

AMYLASE; ANTIDIABETIC AGENT; COLUBRINA ELLIPTICA EXTRACT; GLIBENCLAMIDE; HERBACEOUS AGENT; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLUBRINA; COLUBRINA ELLIPTICA; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; NONHUMAN; RAT;

EID: 23844469460     PISSN: 10273956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wild S, Roglic G, Sicree A, King H. Global burden of diabetes mellitus in the year 2000. Global Burden of Disease, Geneva: WHO, 2003.
2. Lifshitz, G.A. 1989. Prevención primaria de la diabetes mellitus. Revista Médica del IMSS, 27: 1-3.
3. Lee, R.A., Ramirez, O. 1989. Estudio sobre egresos hospitalarios de diabetes mellitus durante 7 años a nivel nacional en el Instituto Mexicano del Seguro Social, 1980-1986. Revista Médica del IMSS, 27: 141-146.
4. Folsh, U.R., Lembcke, R. 1991. Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus. Internist (Berlin), 32: 699-707.
5. Pogatsa, G. 1996. GAT kind of vascular alteration could be influenced positively by oral antidiabetic agents?. Diabetes Research and Clinical Practice, 31: S27-S31.
6. Lebovitz, H.E., Pasmantier, R. 1990. Combination insulin-sulphonylurea therapy. Diabetes Care, 13: 175-181.
7. Bailey, C.J. 1992. Biguanides and NIDDM. Diabetes Care, 15: 755-772.
8. Saltiel, A.R., Olefsky, J.M. 1996. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 45: 1661-1669.
9. Landstedt-Hallin, L., Arner, P., Lins, P.E., Bolinder, J., Olsen, H., Groop, L. 1999. The role of sulphon - ylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Diabetic Medicine, 16: 827-834.
10. Ryan, E.A., Pick, M.E., Marceau, C. 2001. Use of alternative medicine in diabetes mellitus. Diabetic Medicine, 18: 242-245.
11. Alarcón, F., Román, R., Flores, J. 1993. Plantas medicinales usadas en el control de la diabetes mellitus. Ciencia, 44: 363-381.
12. Alarcón-Aguilar, F.J., Roman-Ramos, R., Flores-Saenz, J.L, Jiménez-Estrada, M., Reyes-Chilpa, R., Gonzalez-Paredes, B. 1997. Effects of three mexican medicinal plants (Asteraceae) on blood glucose levels in healthy mice and rabbits. Journal of Ethnopharmacology, 55: 171-177.
13. Oubre, A.Y., Carlson, T. S., King, S. R., Reaven, G. M. 1997. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetología, 40: 614-617.
14. World Health Organization. 1980. Second report of the WHO Expert Committee on Diabetes Mellitus. Technical report series. Geneva, 646:66.
15. Aguilar, C.A., Camacho, P.J., Chino, V. S., Jacquez, R.P., Lopez, V.M. 1998. Plantas medicinales del Herbario del IMSS: su distribución por enfermedades. IMSS, México, p. 119-120.
16. Fernández, N.R. 1985. Rhamnaceae en: Rzedowsky, J., Rzedowsky, C.G., Flora fanerogámica del valle de México. Escuela Nacional de Ciencias Biológicas del I.P.N,. México, Vol II, p. 46-48.
17. Alarcón, A.F., Roman, R.R., Perez, G.S., Aguilar, C.A., Contreras, W.C., Flores, S.J. 1998. Study of the anti-hyperglycemic effect of plants used as antidiabetics. Journal of Ethnopharmacology, 61: 101-110.
18. Salkind NJ, Akey TM. Using SPSS for windows. Analysing and understanding data. New Jersey: Prentice-Hall; 2001.
19. Jackson, J.E., Bressler, R. 1981. Clinical pharmacology of sulfonylurea hypoglycaemic agents. Part 1. Drugs, 22:211-245.
20. Mirsky, I.A. 1956. The role of insulinase and insulinase inhibitors. Metabolism 5, 138-143.
21. Mirsky, I.A, Diengoff, D. 1957. The hypoglycemic response to insulin in man after sulfonylurea by mouth. Journal Clinical Endocrinology, 17: 603-608.
22. Achrekar, S., Kaklij G.S., Pote, M.S., Kelkar, S.M. 1991. Hypoglycemic activity of Eugena jambolana and Ficus bengalensis mechanism of decoction. In Vivo, 5:143-148.
23. Pepato, M.T, Keller, E.H, Baviera, A.M, Kettelhut, I.C, Vendramini, R.C., Brunetti, I.L. 2002. Anti-diabetic activity of Bauhinia forticata decoction in streptozotocin-diabetic rats. Journal of Ethnopharmacology 81, 191-197.
24. Chen, H., Feng, R., Guo Y., Sun L., Jiang, J. 2000. Hypoglycemic effects of aqueous extract of Rhizoma Polygonati Odoraty in mice and rats. Journal of Ethnopharmacology, 74: 225-229.